实验动物与比较医学 ›› 2021, Vol. 41 ›› Issue (1): 46-54.DOI: 10.12300/j.issn.1674-5817.2020.068

• 论著:实验动物与中医药 • 上一篇    下一篇

痰热清注射液的安全药理学动物实验评价

胡俊1, *, 张小利2, *, 杨春1, 陆锦遥1, 王琼1, 谷颖敏1, 谢家骏1, 张超超1, 3#, 田雪松1#   

  1. 1. 上海中医药大学创新中药研究院,上海 201203;
    2. 上海凯宝药业股份有限公司,上海 201401;
    3. 上海中医药大学实验动物中心,上海 201203
  • 收稿日期:2020-06-02 修回日期:2020-11-26 出版日期:2021-02-25 发布日期:2021-02-26
  • 作者简介:胡俊(1986-),男,助理实验师,从事中药毒理学研究。E-mail:hujun19860720@163.com;张小利(1976-),女,硕士,高级工程师,从事中药新药研发。E-mail:xlzhang_ha@163.com。<sup>*</sup>共同第一作者

Safety Pharmacology Evaluation of Tanreqing Injection by Animal Experiment

HU Jun1, *, ZHANG Xiaoli2, *, YANG Chun1, LU Jinyao1, WANG Qiong1, GU Yingmin1, XIE Jiajun1, ZHANG Chaochao1, 3#, TIAN Xuesong1#   

  1. 1. Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China;
    2. Shanghai Kai Bao Pharmaceutical Co., Ltd., Shanghai 201401, China;
    3. Laboratory Animal Research Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2020-06-02 Revised:2020-11-26 Online:2021-02-25 Published:2021-02-26

摘要: 目的 观察痰热清注射液对Beagle犬心血管系统、呼吸系统及ICR小鼠中枢神经系统的影响,为其临床用药提供安全性实验数据。方法 24 只Beagle犬雌雄各半,按体质量随机分为低剂量(2.5 mL原液/kg)、中剂量(5.0 mL原液/kg)、高剂量(10.0 mL原液/kg)痰热清注射液组和溶剂对照组,每组6只;麻醉状态下,右前肢内侧皮下头静脉推注给药,测定给药前、给药40 min和80 min,以及给药后5、10、20、30、60、90、120、150、180、210和240 min的血压、心率、心电图及呼吸情况。160只ICR小鼠雌雄各半,其中60只按体质量随机分为低剂量(3.6 mL原液/kg)、中剂量(6.25 mL原液/kg)、高剂量(12.5 mL原液/kg)痰热清注射液组和溶剂对照、阳性对照组,尾静脉注射给药后观察小鼠一般行为和自发活动;对50只同样分组的小鼠,测定给药后不同时间点的协调运动情况;对另外50只同样分组的小鼠,测定给药后阈下睡眠剂量戊巴比妥钠的协同作用。结果 痰热清注射液各剂量组与相同时间点的溶剂对照组及自身给药前相比,Beagle犬的收缩压、平均动脉压、心电图及呼吸频率的差异均无统计学意义(P>0.05),个别时间点的舒张压和心率差异有统计学意义(P<0.05或P<0.01),但未见明显的剂量或时效相关性。给药后高剂量组ICR小鼠各时间点的自发活动均减少(P<0.05,P<0.01或P<0.001),而协调运动评级在给药后30、50及90 min均明显增高(P<0.05,P<0.01或P<0.001)。结论 在本实验条件下,单次静脉推注痰热清注射液对Beagle犬的心血管、呼吸系统无明显影响;高剂量痰热清注射液对ICR小鼠的中枢神经系统有一定影响,主要表现为自发活动减少,协调运动障碍,可能与其主要有效成分熊胆粉相关。

关键词: 痰热清注射液, 安全药理学, Beagle犬, 小鼠

Abstract: Objective To observe the effects of Tanreqing injection on the cardiovascular and respiratory systems in Beagle dogs and the central nervous system in ICR mice, and to provide the animal safety data for its clinical application. Methods A total of 24 Beagle dogs (12 males and 12 females) were randomly divided into low dose (2.5 mL stock solution/kg), medium dose (5 mL stock solution/kg), high dose (10 mL stock solution/kg) Tanreqing injection groups and a solvent control group according to their body weight; there were 6 dogs in each group with intravenous injection at the right cephalic vein of forelimb under anesthesia. Then the blood pressure, heart rate, electrocardiogram and respiration rate were measured before, during at 40 and 80 min, as well as 5, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 min after administration of Tanreqing injection. A total of 160 ICR mice (half male and female) were selected, and 60 of them were randomly divided into low dose (3.6 mL stock solution/kg), medium dose (6.25 mL stock solution/kg), high dose (12.5 mL stock solution/kg) Tanreqing injection groups, a solvent control and a positive control groups according to their weight, and their general behavior and spontaneous activity were recorded after different doses of Tanreqing injection via the tail vein. The coordinated movement of other 50 mice with the same grouping method were measured at different time points after administration of Tanreqing injection. The synergistic effect of pentobarbital sodium hypnosis at subliminal dosage was tested in the rest of 50 mice with the same grouping method. Results Compared with the solvent control group at the same time point or the group itself before administration, there were no significant differences in systolic pressure, mean arterial pressure, electrocardiogram and respiration rate (all P>0.05) of the Beagle dogs in the Tanreqing injection groups at different doses; while the diastolic pressure and heart rate at some time points were statistically significant (P<0.05 or P<0.01), but there was no dose or time dependent effect. The spontaneous activity of the ICR mice was decreased at each time point (P<0.05, P<0.01 or P<0.001), and the oordinated movement grades were increased at 30, 50 and 90 min after high-dose Tanreqing administration (P<0.05, P<0.01 or P<0.001). Conclusion No significant effects of Tanreqing injection on the cardiovascular and respiratory systems of Beagle dogs are found after single intravenous injection in this experiment. High-dose Tanreqing injection has certain effects on the central nervous system of mice, mainly reduced spontaneous activity and in coordinated movement, which may be related to bear bile powder, the main active ingredient of Tanreqing injection.

Key words: Tanreqing injection, Safety pharmecology, Beagle dogs, Mice

中图分类号: